Where does Vomaris Innovations, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Vomaris Innovations, Inc. ranks #8,513 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Vomaris Innovations, Inc. hold?

Vomaris Innovations, Inc. holds 38 US utility patents granted between 2016 and 2025, spanning 9 technology areas.

What is Vomaris Innovations, Inc.'s Innovation Score?

Vomaris Innovations, Inc. has an Innovation Score of 29.1 out of 100 (30th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Vomaris Innovations, Inc. focus on?

Vomaris Innovations, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 13 patents, ranking #276 of 1,943 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Vomaris Innovations, Inc.'s patent grant rate increasing or decreasing?

Vomaris Innovations, Inc.'s recent grant velocity is +136% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Vomaris Innovations, Inc.'s patents?

Vomaris Innovations, Inc.'s patents average 5.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Vomaris Innovations, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Vomaris Innovations, Inc.

USPTO PatentsView assignee record - 38 granted patents across 9 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Vomaris ranks #8,513 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 9 technology areas.

#8,513
of 49,997 US assignees by volume: 30th percentile
by Innovation Score (29.1/100): 5.6
avg claims per patent: +136%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8513 · US Corporation #8,513 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 38 grants
UPPER-Q #8,513/49,997
PHOTO-FINISH Vandor Group
CPC-NARROW A61N · 9 areas
INNOV-THIN 29.1/100
CLAIMS-SPARSE 5.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +136% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Vandor Group, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vomaris’s 29.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (43%) Velocity 2.5 pts (9%) Breadth 10.6 pts (36%) Claim depth 3.4 pts (12%)

Qualcomm Incorporated · highest

85
Aeroprobe · near

29
Agile Therapeutics · near

29
Anchorfree · near

29
Hanall Biopharma · near

29
Vomaris Innovations · this assignee

29
3D Lighting… · lowest

7

What this shows Vomaris's Innovation Score is 29.1/100 (30th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Vomaris?

Each dot is one of Vomaris’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vomaris’s own 5.6 claims/patent is at or below the 13.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Vomaris vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vomaris's grants concentrate

Vomaris Innovations, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 34.2% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2021 (9 grants) versus a trough of 1 in 2016. By volume, Vomaris sits between Vandor Group, Inc. and Yext, Inc..

Vomaris's three-year grant acceleration

From 2019–2021 to 2022–2024, Vomaris Innovations, Inc. moved from 24 to 9 grants (0.38x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Vandor Group

38
Viega Technology…

38
Vitra

38
Vivex Biomedical

38
WGR

38
Wm T Burnett IP

38
Xevo

38
Yext

38
Vomaris Innovatio… ◀

38

What this shows Vomaris holds 38 patents at rank #8,513, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Vomaris

By rank, the assignees closest to #8,513 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Vomaris's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Vomaris, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Vomaris ranks #276 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (29 here).

Anchorfree Inc. 29 Agile Therapeutics, Inc. 29 Hanall Biopharma Co., Ltd. 29 Aeroprobe Corporation 29

Vomaris's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 30th percentile higher than 30% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Vomaris Innovations, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	2.6%
2017	1	2.6%
2018	2	5.3%
2019	7	18.4%
2020	8	21.1%
2021	9	23.7%
2022	5	13.2%
2023	2	5.3%
2024	2	5.3%
2025partial year	1	2.6%

Which technologies does Vomaris Innovations, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 13

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 11

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 5

A41D - OUTERWEAR; Protective GARMENTS; Accessories 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Vomaris Innovations, Inc.'s patent record in context - here's where to go next.

Vomaris Innovations, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 34.2% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #8,513 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Vomaris Innovations, Inc. against Vandor Group, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.